Part 1 - Proteomic in clinical studies

9.10	Reproducibility of Mass Spectrometry Based Protein Profiles for Diagnosis of Breast Cancer across Clinical Studies
	ON Jensen (Denmark)
9.40	Identification and Validation of Candidate Breast Cancer Biomarkers: A Mass Spectrometric Approach
	V Kulasingam (Canada)
10.10	Proteomic characterization of two monocyte populations in Chronic Myelomonocytic Leukemia (CMML)
	E Solary (France)
10.30 - 11.00 Coffee break – Visit of exhibition - Posters
11.00	Novel renal cancer biomarkers - from discovery to validation using biological fluids
	N Vasudev (UK)
11.30	A new candidate marker for pancreatic carcinoma identified by proteome-wide analysis
	A Leichtle (Germany):

11.45 - 12.30	Plenary lecture
	The Needle-In-The-Haystack Challenge of Cancer Biomarker Discovery and Validation: Best Haystack? Best Tools? Are Needles Really Present?
	DW Speicher (USA)

12.30 - 14.00	Lunch – Visit of exhibition - Posters

Part 2 - Biomarker Discovery to Validation / Quantification

14.00	Paradigm shift in Proteomics: Application to biomarker discovery and validation
	B Domon (Switzerland)
14.30	From Proteomics Biomarker Discovery to Validation
	H Langen (Switzerland)
15.00	Validation of Biomarkers of Breast Cancer Progression and Therapeutic Response via Tissue Microarray Technology and Automated Image Analysis
	WM Gallagher (Ireland)

15.30 - 16.00	Visit of exhibition - Posters

Part 3 - Bio-informatic tools : biostatistical and bioinformatic

16.00	Some aspects of proteome analyses: reproducibility study and power simulations
	P Roy (France)
16.30	International proteomic mass spectrometry comparison: design, concepts, methods and first results
	B Mertens (Netherlands)
17.00	Lab-on-chip technologies and bioinformatics coupled to mass spectrometry for clinical proteomics
	C Paulus (France)

17.15 - 17.45	Coffee break – Visit of exhibition - Posters

Part 4 - Sample collection and clinical proteomic studies

17.45	Biobanking and Proteomics discovery programs using the Cerebrospinal fluid (CSF); preanalytical and analytical consideration.
	S Lehmann (France)
18.15	A Human protein atlas. The Swedish human proteome resource project.
	K Wester (Sweden)
18.45	Plasma/serum proteomics: pre-analytical issues
	JD Tissot (Switzerland)
19.15	Proteomic analysis of RCL2 paraffin-embedded tissues
	J Solassol (France)

20.30	Conference dinner in Dijon